Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Share News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 640.00
Bid: 636.00
Ask: 640.00
Change: -8.00 (-1.23%)
Spread: 4.00 (0.629%)
Open: 646.00
High: 646.00
Low: 632.00
Prev. Close: 648.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Telford Homes Director Sells 275,000 Shares

Wed, 15th Jul 2015 16:13

LONDON (Alliance News) - The following is a summary of director dealings reported in London on Wednesday.
----------
Housebuilder Telford Homes said Joint Managing Director John Fitzgerald sold 25,000 shares at a price of 416.5 pence per share, as part of a series of share sales to raise funds for a divorce settlement.

Fitzgerald had sold 100,000 shares on Tuesday at 421.375p each. He had previously sold 50,000 and 100,000 shares last Wednesday and the Friday prior, respectively.

The share sales were required for Fitzgerald to fulfil a personal financial commitment as part of a divorce settlement, the company said. Wednesday's sale is the last in the series of recent sales relating to his divorce settlement, and no further sales will be undertaken, Telford said.

In total, Fitzgerald sold 275,000 shares, raising about GBP1.2 million before expenses.

Following this transaction, Fitzgerald retains 107,718 shares in the company, representing approximately 0.18% of the company's issued share capital.

The stock closed up 0.5% at 416.00p Wednesday.
----------
7digital Group said co-founder Ben Drury sold 750,000 shares at a price of 14.925 pence per share on Tuesday. Following this transaction, Drury holds 12 million shares, which represents an 11.14% stake in the firm. Shares in the digital music and radio services company closed down 9.0% at 15.69p Wednesday.
----------
International Biotechnology Trust said Caroline Gulliver, a non-executive director, bought 2,500 shares at a price of 569.01 pence per share Tuesday. The purchase is her only holding after being appointed in April. Shares in the trust closed up 2.1% at 587.00p Wednesday.
----------
Aukett Swanke Group said Andrew Murdoch, a director, sold to Chairman Anthony Simmonds 500,000 shares at a price of 7.5 pence per share Wednesday. Following this transaction, Murdoch and Simmonds now hold 13 million and 1 million shares, respectively. These represent beneficial interests of 7.86% and 0.61% of the issued share capital of the architectural and design services firm. The stock closed up 2.6% at 7.44p Wednesday.
----------
Smart Metering Systems said Chief Executive Officer Alan Foy sold 1.1 million shares at a price of 315.5 pence per share. The deal is worth about GBP3.5 million before expenses. Following this transaction, Foy holds 7.8 million shares, which represents 9.05% stake in the firm. Shares in the gas meters company closed down 1.5% at 330.00p Wednesday,
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.



More News
22 Apr 2014 11:52

International Biotechnology Trust Net Asset Value Rises In Half-Year

LONDON (Alliance News) - International Biotechnology Trust PLC said Tuesday that it had seen its net asset value per share rise in the half-year to February 28, 2014, although it under-performed the NASDAQ Biotechnology Index. The trust posted a total return on net asset value per share of

Read more
11 Apr 2014 08:17

STOCKS NEWS EUROPE-Biotechs hit as UK small caps fall

The FTSE Small Cap Index falls 0.4 percent while the junior-listed FTSE AIM All Share Index retreats 0.8 percent, broadly tracking a 0.8 percent drop on the blue-chip FTSE 100 index. The FTSE 250 mid-cap index falls 1.2 percent. Oxford BioMedica declines by 2.9 percent, as brokerage N

Read more
11 Apr 2014 05:13

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
10 Apr 2014 15:09

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
10 Apr 2014 05:09

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
9 Apr 2014 15:25

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
9 Apr 2014 05:30

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
8 Apr 2014 15:14

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
8 Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, April 8 
Netplay TV

Read more
7 Apr 2014 14:50

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, April 8 
Netplay TV

Read more
7 Apr 2014 05:28

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
4 Apr 2014 15:00

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
28 Feb 2014 17:00

DIRECTOR DEALINGS: International Biotechnology Trust Non-Executive, Partners Buy Shares

LONDON (Alliance News) - International Biotechnology Trust PLC said Friday that non-executive director Jim Horsburgh bought 5,000 shares at 330.94 pence each. Horsburgh's total holding following the transaction is 0.02%. Kate Bingham, a partner of the company's investment manager SV L

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
13 Feb 2014 14:54

International Biotechnology Trust Ups Valuation Of Affinium Interest After Sale

LONDON (Alliance News) - The International Biotechnology Trust PLC Thursday said it has upped the valuation of its interest in Affinium Pharmaceuticals, an unquoted portfolio company, after it was sold to Debiopharm Group. In a statement, the trust said it upped the valuation of its interes

Read more

Quickpicks are a member only feature

Login to your account